Immune Correlates of Abscopal Response in a Lead-In Phase II Trial of Neoadjuvant Stereotactic Ablative Radiotherapy (SABR) for Renal Cell Carcinoma Inferior Vena Cava Tumor Thrombus

International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2019.06.430

Related search